PerBlue's Forrest Woolworth (right) shows off his company's exclusive "PerBrew Apollo Ale" with the brewers, MobCraft Beer's Henry Schwartz (left) and Andrew Gierczak (middle).
Photo courtesy of PerBlue.
PerBlue employees got to help brew their company's custom beer.
Photo courtesy of PerBlue.
It’s time for the second installment of our ongoing series exploring the beers on tap at the headquarters of Wisconsin startups. Next up is Madison-based PerBlue, a mobile game developer that has 25 full-time employees. Chief operating officer Forrest Woolworth (pictured above, right, with MobCraft Beer’s Henry Schwartz and Andrew Gierczak) describes playtime at the office:
What’s on tap at PerBlue?
We partnered with MobCraft to brew our very own PerBrew Apollo Ale. It’s a tasty maple brown ale, and we have a stash of 22 oz. bomber bottles on hand. We also have a variety of local craft beers that we replenish on a regular basis. Employees also bring in their own favorite six-packs or new beers to try and share. For the non-beer drinkers, we have an Old Fashioned bar as well as a stock of non-alcoholic ginger beers.
Kegs, bottles, or cans?
Bottles of craft beer, cans of PBR.
Office happy hour?
We grill out about once a week in the summer months for lunch, which many people supplement with a refreshing beer.
Best thing/worst thing about beer in the office?
Best: The principle behind “having a beer” with someone—it’s helped our team become more tight-knit and get to know each other better.
Worst: Spilled beer.
Join us on July 16 for a special two-part gathering that will take a unique and critical look at the Internet today, and where it is heading.
Sponsored · Special Report
Hyperinflation in rents is over
Hughes MarinoSponsored · Whitepaper
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM WatsonSponsored · Whitepaper
Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications
PRA Health Sciences© 2007-2022, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.